KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Blue Bird (BLBD) Asset Writedowns and Impairment (2022)

Blue Bird's Asset Writedowns and Impairment history spans 4 years, with the latest figure at $8.8 million for Q3 2022.

Quarterly Asset Writedowns and Impairment changed N/A to $8.8 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $8.8 million through Sep 2023, changed 0.0% year-over-year, with the annual reading at $7.4 million for FY2025, N/A changed from the prior year.
Asset Writedowns and Impairment came in at $8.8 million for Q3 2022, up from -$5000.0 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $8.8 million in Q3 2022 to a low of $8.8 million in Q3 2022.